118 related articles for article (PubMed ID: 33135677)
1. Lattice-translocation defects in specific crystals of the catalytic head domain of influenza neuraminidase.
Li L; Dai S; Gao GF; Wang J
Acta Crystallogr D Struct Biol; 2020 Nov; 76(Pt 11):1057-1064. PubMed ID: 33135677
[TBL] [Abstract][Full Text] [Related]
2. Structure determination of the 1918 H1N1 neuraminidase from a crystal with lattice-translocation defects.
Zhu X; Xu X; Wilson IA
Acta Crystallogr D Biol Crystallogr; 2008 Aug; D64(Pt 8):843-50. PubMed ID: 18645233
[TBL] [Abstract][Full Text] [Related]
3. Influenza neuraminidase.
Air GM
Influenza Other Respir Viruses; 2012 Jul; 6(4):245-56. PubMed ID: 22085243
[TBL] [Abstract][Full Text] [Related]
4. Structure of influenza virus N7: the last piece of the neuraminidase "jigsaw" puzzle.
Sun X; Li Q; Wu Y; Wang M; Liu Y; Qi J; Vavricka CJ; Gao GF
J Virol; 2014 Aug; 88(16):9197-207. PubMed ID: 24899180
[TBL] [Abstract][Full Text] [Related]
5. An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.
Wilson JR; Guo Z; Reber A; Kamal RP; Music N; Gansebom S; Bai Y; Levine M; Carney P; Tzeng WP; Stevens J; York IA
Antiviral Res; 2016 Nov; 135():48-55. PubMed ID: 27713074
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
7. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
Cheng CK; Tsai CH; Shie JJ; Fang JM
Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the Neuraminidase-Like Protein of Bat Influenza H18N11 Virus Enhance Virus Replication in Mammalian Cells, Mice, and Ferrets.
Zhong G; Fan S; Hatta M; Nakatsu S; Walters KB; Lopes TJS; Wang JI; Ozawa M; Karasin A; Li Y; Tong S; Donis RO; Neumann G; Kawaoka Y
J Virol; 2020 Feb; 94(5):. PubMed ID: 31801857
[TBL] [Abstract][Full Text] [Related]
9. Structure-based design of stabilized recombinant influenza neuraminidase tetramers.
Ellis D; Lederhofer J; Acton OJ; Tsybovsky Y; Kephart S; Yap C; Gillespie RA; Creanga A; Olshefsky A; Stephens T; Pettie D; Murphy M; Sydeman C; Ahlrichs M; Chan S; Borst AJ; Park YJ; Lee KK; Graham BS; Veesler D; King NP; Kanekiyo M
Nat Commun; 2022 Apr; 13(1):1825. PubMed ID: 35383176
[TBL] [Abstract][Full Text] [Related]
10. N-Linked Glycan Sites on the Influenza A Virus Neuraminidase Head Domain Are Required for Efficient Viral Incorporation and Replication.
Östbye H; Gao J; Martinez MR; Wang H; de Gier JW; Daniels R
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699088
[TBL] [Abstract][Full Text] [Related]
11. Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies.
Zhu X; Turner HL; Lang S; McBride R; Bangaru S; Gilchuk IM; Yu W; Paulson JC; Crowe JE; Ward AB; Wilson IA
Cell Host Microbe; 2019 Dec; 26(6):729-738.e4. PubMed ID: 31757767
[TBL] [Abstract][Full Text] [Related]
12. An Amino Acid in the Stalk Domain of N1 Neuraminidase Is Critical for Enzymatic Activity.
Zanin M; Duan S; Wong SS; Kumar G; Baviskar P; Collin E; Russell C; Barman S; Hause B; Webby R
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847354
[TBL] [Abstract][Full Text] [Related]
13. Anti-viral inhibitor binding to influenza neuraminidase by MALDI mass spectrometry.
Swaminathan K; Downard KM
Anal Chem; 2012 Apr; 84(8):3725-30. PubMed ID: 22409142
[TBL] [Abstract][Full Text] [Related]
14. A single E105K mutation far from the active site of influenza B virus neuraminidase contributes to reduced susceptibility to multiple neuraminidase-inhibitor drugs.
Fujisaki S; Takashita E; Yokoyama M; Taniwaki T; Xu H; Kishida N; Sato H; Tashiro M; Imai M; Odagiri T
Biochem Biophys Res Commun; 2012 Dec; 429(1-2):51-6. PubMed ID: 23131559
[TBL] [Abstract][Full Text] [Related]
15. Intact Glycopeptide Analysis of Influenza A/H1N1/09 Neuraminidase Revealing the Effects of Host and Glycosite Location on Site-Specific Glycan Structures.
Zhu B; Shen J; Zhao T; Jiang H; Ma T; Zhang J; Dang L; Gao N; Hu Y; Shi Y; Sun S
Proteomics; 2019 Feb; 19(3):e1800202. PubMed ID: 30578591
[TBL] [Abstract][Full Text] [Related]
16. Structures of aromatic inhibitors of influenza virus neuraminidase.
Jedrzejas MJ; Singh S; Brouillette WJ; Laver WG; Air GM; Luo M
Biochemistry; 1995 Mar; 34(10):3144-51. PubMed ID: 7880809
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the anti-neuraminidase activity of the traditional Chinese medicines and determination of the anti-influenza A virus effects of the neuraminidase inhibitory TCMs in vitro and in vivo.
Tian L; Wang Z; Wu H; Wang S; Wang Y; Wang Y; Xu J; Wang L; Qi F; Fang M; Yu D; Fang X
J Ethnopharmacol; 2011 Sep; 137(1):534-42. PubMed ID: 21699971
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitor resistance in influenza viruses.
Reece PA
J Med Virol; 2007 Oct; 79(10):1577-86. PubMed ID: 17705169
[TBL] [Abstract][Full Text] [Related]
19. Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
Suzuki S; Shichinohe S; Itoh Y; Nakayama M; Ishigaki H; Mori Y; Ogata-Nakahara A; Nguyen CT; Okamatsu M; Sakoda Y; Kida H; Ogasawara K
Antiviral Res; 2020 Jun; 178():104790. PubMed ID: 32272175
[TBL] [Abstract][Full Text] [Related]
20. Structure and functions of influenza virus neuraminidase.
Gong J; Xu W; Zhang J
Curr Med Chem; 2007; 14(1):113-22. PubMed ID: 17266572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
